{"transactions":[{"id":2397392,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-14T21:49:27.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2023, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 200,000 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,118,893 shares of common stock, which options vest according to their terms, and (ii) 68,600 shares of common stock held directly."}],"balance_after":200000,"derivative":{"exercise_price":30.44,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-22-009341","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919122009341/doc4.xml","form_type":"4"}},{"id":2460664,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-12-22T23:42:10.000Z","date":"2021-12-20","kind":"exercise","acquired":false,"shares":36645,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option grant was issued on February 1, 2012, is fully vested and exercisable until its expiration date of January 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"In addition to the remaining options to purchase 0 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,118,893 shares of common stock, which options vest according to their terms, and (ii) 68,600 shares of common stock held directly."}],"balance_after":0,"derivative":{"exercise_price":1.12,"expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":36645},"source":{"system":"sec-edgar","filing":"0001209191-21-070986","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121070986/doc4.xml","form_type":"4"}},{"id":2460663,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-22T23:42:10.000Z","date":"2021-12-20","kind":"sale","acquired":false,"shares":5522,"price":36.4046,"value":201026.2012,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.26 to $36.52, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":68600,"source":{"system":"sec-edgar","filing":"0001209191-21-070986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121070986/doc4.xml","form_type":"4"}},{"id":2460662,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-22T23:42:10.000Z","date":"2021-12-20","kind":"sale","acquired":false,"shares":19208,"price":35.7547,"value":686776.2776,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.26 to $36.25, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":74122,"source":{"system":"sec-edgar","filing":"0001209191-21-070986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121070986/doc4.xml","form_type":"4"}},{"id":2460661,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-22T23:42:10.000Z","date":"2021-12-20","kind":"sale","acquired":false,"shares":11915,"price":34.8935,"value":415756.0525,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.25 to $35.23, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":93330,"source":{"system":"sec-edgar","filing":"0001209191-21-070986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121070986/doc4.xml","form_type":"4"}},{"id":2460660,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-12-22T23:42:10.000Z","date":"2021-12-20","kind":"exercise","acquired":true,"shares":36645,"price":1.12,"value":41042.4,"ownership":{"direct":true},"balance_after":105245,"source":{"system":"sec-edgar","filing":"0001209191-21-070986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121070986/doc4.xml","form_type":"4"}},{"id":2506514,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-11-17T22:20:34.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":964,"price":22.03,"value":21236.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock acquired pursuant to the Issuer's Employee Stock Purchase Plan (\"ESPP\"), for the purchase period through November 15, 2021. In accordance with the ESPP, these shares were purchased at 85% of the lesser of the closing price of the Issuer's Common Stock on May 17, 2021 and November 15, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the reporting person's common stock directly held as set forth in Table I above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,155,538 shares of common stock, which options vest according to their terms."}],"balance_after":68600,"source":{"system":"sec-edgar","filing":"0001209191-21-065173","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121065173/doc4.xml","form_type":"4"}},{"id":2522621,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-11-05T22:24:17.000Z","date":"2021-11-05","kind":"exercise","acquired":false,"shares":14302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option grant was issued on December 9, 2011, is fully vested and exercisable until its expiration date of December 8, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 0 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,155,538 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly."}],"balance_after":0,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":14302},"source":{"system":"sec-edgar","filing":"0001209191-21-063263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121063263/doc4.xml","form_type":"4"}},{"id":2522620,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-11-05T22:24:17.000Z","date":"2021-11-04","kind":"exercise","acquired":false,"shares":6059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option grant was issued on December 9, 2011, is fully vested and exercisable until its expiration date of December 8, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 0 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,155,538 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly."}],"balance_after":14302,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":6059},"source":{"system":"sec-edgar","filing":"0001209191-21-063263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121063263/doc4.xml","form_type":"4"}},{"id":2522619,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-11-05T22:24:17.000Z","date":"2021-11-05","kind":"sale","acquired":false,"shares":14302,"price":35,"value":500570.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":67636,"source":{"system":"sec-edgar","filing":"0001209191-21-063263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121063263/doc4.xml","form_type":"4"}},{"id":2522618,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-11-05T22:24:17.000Z","date":"2021-11-05","kind":"exercise","acquired":true,"shares":14302,"price":1.12,"value":16018.24,"ownership":{"direct":true},"balance_after":81938,"source":{"system":"sec-edgar","filing":"0001209191-21-063263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121063263/doc4.xml","form_type":"4"}},{"id":2522617,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-11-05T22:24:17.000Z","date":"2021-11-04","kind":"sale","acquired":false,"shares":6059,"price":35,"value":212065.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":67636,"source":{"system":"sec-edgar","filing":"0001209191-21-063263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121063263/doc4.xml","form_type":"4"}},{"id":2522616,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-11-05T22:24:17.000Z","date":"2021-11-04","kind":"exercise","acquired":true,"shares":6059,"price":1.12,"value":6786.08,"ownership":{"direct":true},"balance_after":73695,"source":{"system":"sec-edgar","filing":"0001209191-21-063263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121063263/doc4.xml","form_type":"4"}},{"id":2528356,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-02T21:53:46.000Z","date":"2021-11-01","kind":"exercise","acquired":false,"shares":36646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option grant was issued on January 31, 2012 and became fully vested as of January 31, 2016, and is exercisable until its expiration date of January 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"In addition to the remaining options to purchase 36,645 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,139,254 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly."}],"balance_after":36645,"derivative":{"exercise_price":1.12,"expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":36646},"source":{"system":"sec-edgar","filing":"0001209191-21-062481","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121062481/doc4.xml","form_type":"4"}},{"id":2528355,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-11-02T21:53:46.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":2559,"price":32.8798,"value":84139.4082,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.85 to $32.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":67636,"source":{"system":"sec-edgar","filing":"0001209191-21-062481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121062481/doc4.xml","form_type":"4"}},{"id":2528354,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-11-02T21:53:46.000Z","date":"2021-11-01","kind":"sale","acquired":false,"shares":34087,"price":32.2694,"value":1099967.0378,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.84 to $32.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":70195,"source":{"system":"sec-edgar","filing":"0001209191-21-062481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121062481/doc4.xml","form_type":"4"}},{"id":2528353,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-11-02T21:53:46.000Z","date":"2021-11-01","kind":"exercise","acquired":true,"shares":36646,"price":1.12,"value":41043.52,"ownership":{"direct":true},"balance_after":104282,"source":{"system":"sec-edgar","filing":"0001209191-21-062481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121062481/doc4.xml","form_type":"4"}},{"id":2532639,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-10-28T23:54:42.000Z","date":"2021-10-26","kind":"exercise","acquired":false,"shares":15993,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option grant was issued on January 31, 2012 and became fully vested as of January 31, 2016, and is exercisable until its expiration date of January 31, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"In addition to the remaining options to purchase 73,291 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,139,254 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly."}],"balance_after":73291,"derivative":{"exercise_price":1.12,"expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":15993},"source":{"system":"sec-edgar","filing":"0001209191-21-061975","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121061975/doc4.xml","form_type":"4"}},{"id":2532638,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-10-28T23:54:42.000Z","date":"2021-10-26","kind":"sale","acquired":false,"shares":15993,"price":30,"value":479790.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":67636,"source":{"system":"sec-edgar","filing":"0001209191-21-061975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121061975/doc4.xml","form_type":"4"}},{"id":2532637,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-10-28T23:54:42.000Z","date":"2021-10-26","kind":"exercise","acquired":true,"shares":15993,"price":1.12,"value":17912.16,"ownership":{"direct":true},"balance_after":83629,"source":{"system":"sec-edgar","filing":"0001209191-21-061975","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121061975/doc4.xml","form_type":"4"}},{"id":2562868,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-21T21:38:35.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 20,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,208,177 shares of common stock, which options vest according to their terms, and (ii) 67,636 shares of common stock held directly."}],"balance_after":20361,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-057077","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121057077/doc4.xml","form_type":"4"}},{"id":2562867,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-09-21T21:38:35.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":10000,"price":1.12,"value":11200.0,"ownership":{"direct":true},"balance_after":67636,"source":{"system":"sec-edgar","filing":"0001209191-21-057077","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121057077/doc4.xml","form_type":"4"}},{"id":2714113,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-05-13T20:50:29.000Z","date":"2021-05-12","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 30,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,208,177 shares of common stock, which options vest according to their terms, and (ii) 57,636 shares of common stock held directly."}],"balance_after":30361,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-032377","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121032377/doc4.xml","form_type":"4"}},{"id":2714112,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2021-05-13T20:50:29.000Z","date":"2021-05-12","kind":"exercise","acquired":true,"shares":10000,"price":1.12,"value":11200.0,"ownership":{"direct":true},"balance_after":57636,"source":{"system":"sec-edgar","filing":"0001209191-21-032377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121032377/doc4.xml","form_type":"4"}},{"id":2862649,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Stock Option (right to buy)","published_at":"2021-02-13T02:29:46.000Z","date":"2021-02-10","kind":"grant","acquired":true,"shares":119700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 10, 2022, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":119700,"derivative":{"exercise_price":29.7,"expiration_date":"2031-02-09","underlying":"Common Stock","underlying_shares":119700},"source":{"system":"sec-edgar","filing":"0001209191-21-010518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919121010518/doc4.xml","form_type":"4"}},{"id":3217267,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-03-10T21:02:50.000Z","date":"2020-03-10","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 40,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,088,477 shares of common stock, which options vest according to their terms, and (ii) 47,636 shares of common stock held directly."}],"balance_after":40361,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-017742","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919120017742/doc4.xml","form_type":"4"}},{"id":3217266,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-03-10T21:02:50.000Z","date":"2020-03-10","kind":"exercise","acquired":true,"shares":10000,"price":1.12,"value":11200.0,"ownership":{"direct":true},"balance_after":47636,"source":{"system":"sec-edgar","filing":"0001209191-20-017742","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919120017742/doc4.xml","form_type":"4"}},{"id":3286353,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-02-06T22:46:58.000Z","date":"2020-02-05","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 50,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 1,088,477 shares of common stock, which options vest according to their terms, and (ii) 37,636 shares of common stock held directly."}],"balance_after":50361,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-20-007246","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919120007246/doc4.xml","form_type":"4"}},{"id":3286352,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2020-02-06T22:46:58.000Z","date":"2020-02-05","kind":"exercise","acquired":true,"shares":10000,"price":1.12,"value":11200.0,"ownership":{"direct":true},"balance_after":37636,"source":{"system":"sec-edgar","filing":"0001209191-20-007246","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919120007246/doc4.xml","form_type":"4"}},{"id":3338456,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-12-17T23:28:10.000Z","date":"2019-12-13","kind":"grant","acquired":true,"shares":280000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":280000,"derivative":{"exercise_price":15.73,"expiration_date":"2029-12-12","underlying":"Common Stock","underlying_shares":280000},"source":{"system":"sec-edgar","filing":"0001209191-19-060981","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119060981/doc4.xml","form_type":"4"}},{"id":3359712,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-11-25T21:49:06.000Z","date":"2019-11-22","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining options to purchase 60,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 808,477 shares of common stock, which options vest according to their terms, and (ii) 27,636 shares of common stock held directly."}],"balance_after":60361,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-057952","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119057952/doc4.xml","form_type":"4"}},{"id":3359711,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-11-25T21:49:06.000Z","date":"2019-11-22","kind":"exercise","acquired":true,"shares":10000,"price":1.12,"value":11200.0,"ownership":{"direct":true},"balance_after":27636,"source":{"system":"sec-edgar","filing":"0001209191-19-057952","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119057952/doc4.xml","form_type":"4"}},{"id":3492389,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-06-12T21:00:25.000Z","date":"2019-06-10","kind":"sale","acquired":false,"shares":454,"price":76.31,"value":34644.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"The Reporting Person also holds options to purchase up to an aggregate of 878,838 shares of common stock, which options vest according to their terms, in addition to the 17,636 shares of common stock held directly as set forth in Table I above."}],"balance_after":17636,"source":{"system":"sec-edgar","filing":"0001209191-19-036426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119036426/doc4.xml","form_type":"4"}},{"id":3492388,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-06-12T21:00:25.000Z","date":"2019-06-10","kind":"sale","acquired":false,"shares":1994,"price":75.863,"value":151270.822,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.24 to $76.13 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":18090,"source":{"system":"sec-edgar","filing":"0001209191-19-036426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119036426/doc4.xml","form_type":"4"}},{"id":3492387,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-06-12T21:00:25.000Z","date":"2019-06-10","kind":"sale","acquired":false,"shares":5000,"price":74.6825,"value":373412.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.20 to $75.12 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":20084,"source":{"system":"sec-edgar","filing":"0001209191-19-036426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119036426/doc4.xml","form_type":"4"}},{"id":3492386,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-06-12T21:00:25.000Z","date":"2019-06-10","kind":"sale","acquired":false,"shares":6440,"price":73.7014,"value":474637.016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.20 to $74.15 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":25084,"source":{"system":"sec-edgar","filing":"0001209191-19-036426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119036426/doc4.xml","form_type":"4"}},{"id":3492385,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-06-12T21:00:25.000Z","date":"2019-06-10","kind":"sale","acquired":false,"shares":8540,"price":72.6446,"value":620384.884,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.16 to $73.15 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":31524,"source":{"system":"sec-edgar","filing":"0001209191-19-036426","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119036426/doc4.xml","form_type":"4"}},{"id":3552574,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-04-18T22:34:09.000Z","date":"2019-04-17","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In addition to the remaining option to purchase 70,361 shares of common stock as set forth in Table II, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 808,477 shares of common stock, which options vest according to their terms, and (ii) 40,064 shares of common stock held directly."}],"balance_after":70361,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-19-025283","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119025283/doc4.xml","form_type":"4"}},{"id":3552573,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-04-18T22:34:09.000Z","date":"2019-04-17","kind":"exercise","acquired":true,"shares":10000,"price":1.12,"value":11200.0,"ownership":{"direct":true},"balance_after":40064,"source":{"system":"sec-edgar","filing":"0001209191-19-025283","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119025283/doc4.xml","form_type":"4"}},{"id":3665491,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-02-11T22:38:22.000Z","date":"2019-02-08","kind":"grant","acquired":false,"shares":94000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 8, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":94000,"derivative":{"exercise_price":68.89,"expiration_date":"2029-02-07","underlying":"Common Stock","underlying_shares":94000},"source":{"system":"sec-edgar","filing":"0001209191-19-009043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119009043/doc4.xml","form_type":"4"}},{"id":3694404,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-01-17T00:11:52.000Z","date":"2019-01-14","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"In addition to the remaining options to purchase 89,284 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 705,554 shares of common stock, which options vest according to their terms, and (ii) 30,064 shares of common stock held directly."}],"balance_after":89284,"derivative":{"exercise_price":1.12,"expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001209191-19-003997","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119003997/doc4.xml","form_type":"4"}},{"id":3694403,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-01-17T00:11:52.000Z","date":"2019-01-14","kind":"sale","acquired":false,"shares":12240,"price":71.1033,"value":870304.392,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.00 to $71.60 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30064,"source":{"system":"sec-edgar","filing":"0001209191-19-003997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119003997/doc4.xml","form_type":"4"}},{"id":3694402,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-01-17T00:11:52.000Z","date":"2019-01-14","kind":"sale","acquired":false,"shares":27760,"price":70.6494,"value":1961227.344,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.00 to $70.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42304,"source":{"system":"sec-edgar","filing":"0001209191-19-003997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119003997/doc4.xml","form_type":"4"}},{"id":3694401,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2019-01-17T00:11:52.000Z","date":"2019-01-14","kind":"exercise","acquired":true,"shares":40000,"price":1.12,"value":44800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":70064,"source":{"system":"sec-edgar","filing":"0001209191-19-003997","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919119003997/doc4.xml","form_type":"4"}},{"id":3726380,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-19T02:46:18.000Z","date":"2018-12-14","kind":"exercise","acquired":false,"shares":41728,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"In addition to the remaining options to purchase 129,284 shares of common stock as set forth in Table II above, the Reporting Person also holds  (i) additional options to purchase up to an aggregate of 705,554 shares of common stock, which options vest according to their terms, and (ii) 30,064 shares of common stock held directly."}],"balance_after":129284,"derivative":{"exercise_price":1.12,"expiration_date":"2022-01-31","underlying":"Common Stock","underlying_shares":41728},"source":{"system":"sec-edgar","filing":"0001209191-18-063382","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063382/doc4.xml","form_type":"4"}},{"id":3726379,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-19T02:46:18.000Z","date":"2018-12-14","kind":"sale","acquired":false,"shares":7800,"price":70.5101,"value":549978.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.33 to $70.98 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30064,"source":{"system":"sec-edgar","filing":"0001209191-18-063382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063382/doc4.xml","form_type":"4"}},{"id":3726378,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-19T02:46:18.000Z","date":"2018-12-14","kind":"sale","acquired":false,"shares":9084,"price":69.6794,"value":632967.6696,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.31 to $70.30 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":37864,"source":{"system":"sec-edgar","filing":"0001209191-18-063382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063382/doc4.xml","form_type":"4"}},{"id":3726377,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-19T02:46:18.000Z","date":"2018-12-14","kind":"sale","acquired":false,"shares":24844,"price":68.887,"value":1711428.628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.31 to $69.30 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":46948,"source":{"system":"sec-edgar","filing":"0001209191-18-063382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063382/doc4.xml","form_type":"4"}},{"id":3726376,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-19T02:46:18.000Z","date":"2018-12-14","kind":"exercise","acquired":true,"shares":41728,"price":1.12,"value":46735.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":71792,"source":{"system":"sec-edgar","filing":"0001209191-18-063382","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118063382/doc4.xml","form_type":"4"}},{"id":3733790,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-12","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option is fully vested and immediately exercisable."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F9","text":"In addition to the remaining options to purchase 80,361 shares of common stock as set forth in Table II above, the Reporting Person also holds (i) additional options to purchase up to an aggregate of 796,205 shares of common stock, which options vest according to their terms, and (ii) 30,064 shares of common stock held directly."}],"balance_after":80361,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733789,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-10","kind":"exercise","acquired":false,"shares":30587,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The stock option is fully vested and immediately exercisable."}],"balance_after":110361,"derivative":{"exercise_price":1.12,"expiration_date":"2021-12-08","underlying":"Common Stock","underlying_shares":30587},"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733788,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-12","kind":"sale","acquired":false,"shares":8324,"price":72.8758,"value":606618.1592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.52 to $73.04 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":30064,"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733787,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-12","kind":"sale","acquired":false,"shares":9673,"price":71.9237,"value":695717.9501,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.51 to $72.48 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":38388,"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733786,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-12","kind":"sale","acquired":false,"shares":12003,"price":71.1056,"value":853480.5168,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.51 to $71.49 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":48061,"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733785,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-12","kind":"exercise","acquired":true,"shares":30000,"price":1.12,"value":33600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":60064,"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733784,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-11","kind":"sale","acquired":false,"shares":4998,"price":70.83,"value":354008.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":30064,"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733783,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-10","kind":"sale","acquired":false,"shares":4964,"price":72.4829,"value":359805.1156,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.13 to $73.07 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":35062,"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733782,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-10","kind":"sale","acquired":false,"shares":10347,"price":71.4894,"value":739700.8218,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $71.01 to $71.99 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":40026,"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733781,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-10","kind":"sale","acquired":false,"shares":15276,"price":70.5736,"value":1078082.3136,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.01 to $71.00 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":50373,"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3733780,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-12-13T01:06:02.000Z","date":"2018-12-10","kind":"exercise","acquired":true,"shares":30587,"price":1.12,"value":34257.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person."}],"balance_after":65649,"source":{"system":"sec-edgar","filing":"0001209191-18-062336","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118062336/doc4.xml","form_type":"4"}},{"id":3869145,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-07-11T21:09:01.000Z","date":"2018-07-09","kind":"exercise","acquired":false,"shares":6208,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.61,"expiration_date":"2021-02-23","underlying":"Common Stock","underlying_shares":6208},"source":{"system":"sec-edgar","filing":"0001209191-18-042363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118042363/doc4.xml","form_type":"4"}},{"id":3869144,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-07-11T21:09:01.000Z","date":"2018-07-09","kind":"exercise","acquired":false,"shares":1428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.24,"expiration_date":"2020-02-09","underlying":"Common Stock","underlying_shares":1428},"source":{"system":"sec-edgar","filing":"0001209191-18-042363","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118042363/doc4.xml","form_type":"4"}},{"id":3869143,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-07-11T21:09:01.000Z","date":"2018-07-09","kind":"exercise","acquired":true,"shares":6208,"price":1.61,"value":9994.88,"ownership":{"direct":true},"balance_after":35062,"source":{"system":"sec-edgar","filing":"0001209191-18-042363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118042363/doc4.xml","form_type":"4"}},{"id":3869142,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-07-11T21:09:01.000Z","date":"2018-07-09","kind":"exercise","acquired":true,"shares":1428,"price":2.24,"value":3198.72,"ownership":{"direct":true},"balance_after":28854,"source":{"system":"sec-edgar","filing":"0001209191-18-042363","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118042363/doc4.xml","form_type":"4"}},{"id":3898044,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-06-11T20:38:20.000Z","date":"2018-06-08","kind":"exercise","acquired":false,"shares":22428,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option is fully vested and immediately exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.59,"expiration_date":"2018-12-08","underlying":"Common Stock","underlying_shares":22428},"source":{"system":"sec-edgar","filing":"0001209191-18-036984","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118036984/doc4.xml","form_type":"4"}},{"id":3898043,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2018-06-11T20:38:20.000Z","date":"2018-06-08","kind":"exercise","acquired":true,"shares":22428,"price":2.59,"value":58088.52,"ownership":{"direct":true},"balance_after":27426,"source":{"system":"sec-edgar","filing":"0001209191-18-036984","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118036984/doc4.xml","form_type":"4"}},{"id":4084659,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-01-30T21:12:21.000Z","date":"2018-01-26","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on January 26, 2019, and thereafter vests as to\n1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the\nReporting Person on each vesting date."}],"balance_after":63000,"derivative":{"exercise_price":106.84,"expiration_date":"2028-01-25","underlying":"Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001209191-18-005995","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919118005995/doc4.xml","form_type":"4"}},{"id":4417010,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-02-28T23:40:03.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable as to 25% of the shares subject to the option on February 24, 2018, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date."}],"balance_after":225000,"derivative":{"exercise_price":24.6,"expiration_date":"2027-02-23","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001209191-17-015443","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919117015443/doc4.xml","form_type":"4"}},{"id":4475027,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Series D Preferred","published_at":"2017-01-31T21:44:26.000Z","date":"2017-01-31","kind":"exercise","acquired":false,"shares":2020,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2020},"source":{"system":"sec-edgar","filing":"0001209191-17-006402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919117006402/doc4.xml","form_type":"4"}},{"id":4475026,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Series C-1 Preferred","published_at":"2017-01-31T21:44:26.000Z","date":"2017-01-31","kind":"exercise","acquired":false,"shares":781,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":781},"source":{"system":"sec-edgar","filing":"0001209191-17-006402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919117006402/doc4.xml","form_type":"4"}},{"id":4475025,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Series C Preferred","published_at":"2017-01-31T21:44:26.000Z","date":"2017-01-31","kind":"exercise","acquired":false,"shares":2197,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":2197},"source":{"system":"sec-edgar","filing":"0001209191-17-006402","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919117006402/doc4.xml","form_type":"4"}},{"id":4475024,"issuer":{"id":4640,"kind":"organization","name":"ANAPTYSBIO, INC","symbol":"ANAB"},"owners":[{"id":130463,"kind":"person","name":"Suria Hamza","position":1,"cik":"0001654495","reported_name":"Suria Hamza","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CEO"}}],"security":"Common Stock","published_at":"2017-01-31T21:44:26.000Z","date":"2017-01-31","kind":"exercise","acquired":true,"shares":4998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In connection with the consummation of the Issuer's initial public offering on January 31, 2017, each share of Series C Preferred Stock, Series C-1 Preferred Stock and Series D Preferred Stock automatically converted into one (1) share of Common Stock for no additional consideration, and had no expiration date. All shares of Common Stock issued upon conversion were aggregated."}],"balance_after":4998,"source":{"system":"sec-edgar","filing":"0001209191-17-006402","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1370053/000120919117006402/doc4.xml","form_type":"4"}}]}